Yunfei Wang

发表

Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy

H. Gu, Ting Liu, W. Di, 2015, International journal of nanomedicine.

LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade

P. Hwu, U. Marathi, Leila J. Williams, 2022, The Journal of clinical investigation.

Three transcription factors and the way immune cells affected by different plasma change in opposite ways in the development of the syndrome of pre‐eclampsia

Jianhua Lin, W. Di, Zhou Liang, 2014, Chinese medical journal.

ARF-derived peptide sensitizes ovarian cancer cells to Cisplatin

Ting Liu, W. Di, Jinhua Zhou, 2018, Translational Cancer Research.

Toxicity and therapy of cisplatin-loaded EGF modified mPEG-PLGA-PLL nanoparticles for SKOV3 cancer in mice.

Ying Sun, Mingjie Zhu, Y. Duan, 2013, Biomaterials.

FOXM1 Modulates Cisplatin Sensitivity by Regulating EXO1 in Ovarian Cancer

Ting Liu, W. Di, Yifeng He, 2014, PloS one.

MicroRNA-7 Inhibits Tumor Metastasis and Reverses Epithelial-Mesenchymal Transition through AKT/ERK1/2 Inactivation by Targeting EGFR in Epithelial Ovarian Cancer

W. Di, L. Dai, L. Qiu, 2014, PloS one.

Citrate Synthase Expression Affects Tumor Phenotype and Drug Resistance in Human Ovarian Carcinoma

Ting Liu, W. Di, Shu Zhang, 2014, PloS one.

Specific cell targeting with APRPG conjugated PEG-PLGA nanoparticles for treating ovarian cancer.

Y. Duan, W. Di, Qi Wang, 2014, Biomaterials.

Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1α pathway in human ovarian cancer in vitro

Ting Liu, W. Di, Shu Zhang, 2014, Journal of Ovarian Research.

Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.

Ting Liu, W. Di, L. Qiu, 2014, Biomaterials.